Neurovascular Devices/Interventional Neurology Market worth 2.62 Billion USD by 2021

1
MarketsandMarkets Presents
Neurovascular Devices/Interventional Neurology
Market worth 2.62 Billion USD by 2021
http//www.marketsandmarkets.com/Market-Reports/ne
urointerventional-neurostimulation-devices-market-
847.html  
2
The report "Neurovascular Devices/Interventional
Neurology Market by Product (Embolic Coils,
Stents, Neurothrombectomy Devices,
Microcatheters, Balloon Occlusion Devices, Flow
Diversion Devices, Clot Retrievers), Pathology
(Aneurysm, AVM) - Global Forecasts to 2021", This
report studies the neurovascular
devices/interventional neurology market over the
forecast period of 2016 to 2021. The market is
expected to reach USD 2.62 Billion by 2021 at a
CAGR of 8.6 during 2016 to 2021. Browse 100
market data tables and 52 figures spread through
193 pages and in-depth TOC on "Neurovascular
Devices/Interventional Neurology Markert
http//www.marketsandmarkets.com/Market-Reports/
neurointerventional-neurostimulation-devices-marke
t-847.html Early buyers will receive 10
customization on This reports. A number of
factors such as growing target patient
population, ongoing product development
commercialization, favorable medical
reimbursements, expansion of healthcare
infrastructure across emerging markets, growing
market demand for effective neurovascular
devices, increasing number of researches in the
field of neurovascular therapies
http//www.marketsandmarkets.com/Market-Reports/ne
urointerventional-neurostimulation-devices-market-
847.html  
3
Rising demand for minimally invasive
neurosurgical procedures, and increasing
awareness among neurosurgeons about minimally
invasive surgical procedures. However, dearth
of skilled neurosurgeons and stringent regulatory
policies are the key challenges faced by leading
players in the global neurovascular
devices/interventional neurology market. On the
basis of products, the neurovascular
devices/interventional neurology market is
segmented into aneurysm coiling and embolization
devices, cerebral balloon angioplasty and
stenting systems, support devices, and
neurothrombectomy devices. The aneurysm coiling
and embolization devices segment is expected to
hold the largest share of the interventional
neurology market in 2016. The large market share
of this segment can be attributed to the growing
end-user preference for minimally invasive
neurosurgical procedures and increasing market
availability of embolic coils for neurovascular
treatment.
http//www.marketsandmarkets.com/Market-Reports/ne
urointerventional-neurostimulation-devices-market-
847.html  
4
On the basis of pathology, the neurovascular
devices/interventional neurology market is
segmented into ischemic strokes, cerebral
aneurysm, arteriovenous malformations fistulas,
and other diseases. The ischemic strokes segment
is expected to hold the largest share of the
global neurovascular devices/interventional
neurology market in 2016. Dominant market
position of ischemic strokes segment is
attributed to rising prevalence of ischemic
stroke (coupled with exposure of larger
proportion of global population to major risk
factors such as smoking and diabetes), and
increasing patient preference for minimally
invasive therapeutic neurosurgical
technologies. The Sample Report For This Report_at_
http//www.marketsandmarkets.com/requestsample.as
p?id847 On the basis of geography, this market
is classified into four regions, namely, North
America, Europe, Asia-Pacific, and the Rest of
the World. In 2016, the global interventional
neurology market is expected to be dominated by
North America.
http//www.marketsandmarkets.com/Market-Reports/ne
urointerventional-neurostimulation-devices-market-
847.html  
5
North American region is expected to dominate the
neurovascular devices/interventional neurology
market during study period owing to significant
adoption of neurovascular devices among
neurosurgeons in neurovascular disease treatment,
growing number of clinical trials (that aim to
evaluate the therapeutic efficacy of
neurovascular devices) and significant medical
reimbursement available in the U.S. for
neurosurgical procedures. Get The PDF Brochure
For This Report_at_ http//www.marketsandmarkets.com
/pdfdownload.asp?id847   As of 2015, Stryker
Corporation (U.S.), Medtronic plc (U.S.), Johnson
Johnson (U.S.), and Terumo Corporation (Japan)
are the top four players in the market. Other
prominent players present in the market include
Penumbra, Inc. (U.S.), Abbott Laboratories
(U.S.), Merit Medical Systems, Inc. (U.S.), W. L.
Gore Associates, Inc. (U.S.), and MicroPort
Scientific Corporation (China), among others.
http//www.marketsandmarkets.com/Market-Reports/ne
urointerventional-neurostimulation-devices-market-
847.html  
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/ne
urointerventional-neurostimulation-devices-market-
847.html  
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets